Emtricitabine Impurity 22 - Request Quote
Emtricitabine Impurity 22
| SZ CAT No: | SZ-E010054 |
| CAS No | NA |
| Mol.F. | C8H10FN3O3S |
| Mol.Wt. | 247.2 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Emtricitabine Impurity 22 is chemically 4-Amino-5-fluoro-1-((2R,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one compound with 4-amino-5-fluoro-1-((2S,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one (1:1). Emtricitabine Impurity 22 is supplied with detailed characterization data compliant with regulatory guideline. Emtricitabine Impurity 22 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Emtricitabine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Emtricitabine Impurity 22
Purchase Emtricitabine Impurity 22
Emtricitabine Impurity 22 suppliers
Emtricitabine Impurity 22 manufacturers
Emtricitabine Impurity 22 price
Order Emtricitabine Impurity 22
Enquire Emtricitabine Impurity 22
Emtricitabine Impurity 22 cost
Emtricitabine Impurity 22 Supplier
Emtricitabine Impurity 22 Distributor
Emtricitabine Impurity 22 for Method Validation
Emtricitabine Reference Standard
Emtricitabine Impurity 22 for ANDA Filing
Emtricitabine Impurity 22 for Forced Degradation Studies
Emtricitabine Impurity 22 Identification Standards
Emtricitabine Impurity 22 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


